stimulant
Showing 26 - 50 of 802
Methamphetamine Abuse Trial in New York (Affect Methamphetamine Treatment Program)
Completed
- Methamphetamine Abuse
- Affect Methamphetamine Treatment Program
-
New York, New YorkAffect Therapeutics
Feb 23, 2022
Intellectual Disability, Fragile X Syndrome, Down Syndrome Trial (Methylphenidate Oral Solution)
Not yet recruiting
- Intellectual Disability
- +3 more
- Methylphenidate Oral Solution
- (no location specified)
Mar 17, 2022
Change in Cognitive Function in Stimulant Users
Recruiting
- Cognitive Dysfunction
- +4 more
- Cognitive Assessment
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 21, 2021
Stimulant Use Trial in Chicago (Methamphetamine, oral tablet)
Recruiting
- Stimulant Use
- Methamphetamine
- placebo oral tablet
-
Chicago, IllinoisUniversity of Chicago
May 19, 2022
Epilepsy, Depression Trial in Rochester (Vagal nerve stimulant)
Not yet recruiting
- Epilepsy
- Depression
- Vagal nerve stimulant
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 14, 2023
ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant
Not yet recruiting
- ADHD
- Autism Spectrum Disorder
- Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
- Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
-
Irvine, California
- +11 more
Jun 14, 2023
Stimulant Abuse, HIV Prevention, Substance Abuse Trial in Miami, Boston (IMPACT, Standard of Care)
Recruiting
- Stimulant Abuse
- +2 more
- IMPACT
- Standard of Care
-
Miami, Florida
- +1 more
Nov 10, 2021
Neurofibromatosis Type 1 Trial in Washington (CogmedRM, Mobymax)
Completed
- Neurofibromatosis Type 1
- CogmedRM
- Mobymax
-
Washington, District of ColumbiaChildren's National Health System
Mar 2, 2022
Attention Deficit/Hyperactivity Disorder Trial in Boston (SMS Intervention)
Active, not recruiting
- Attention Deficit/Hyperactivity Disorder
- SMS Intervention
-
Boston, MassachusettsMassachusetts General Hospital
Jan 14, 2022
Prescription Drug Abuse (Not Dependent), Intentional Misuse Trial in Hartford, San Marcos, Laramie (Web-based presentation,
Recruiting
- Prescription Drug Abuse (Not Dependent)
- Intentional Misuse
- Web-based placebo presentation
- Web-based simulation active intervention
-
Hartford, Connecticut
- +2 more
Apr 1, 2022
Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered Trial in Boston (Methylphenidate)
Recruiting
- Brain Injury Traumatic Severe (Diagnosis)
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 1, 2022
Substance Use Disorders, Alcohol Use Disorder, Stimulant-Related Disorder Trial (Cognitive Behavioral Therapy)
Not yet recruiting
- Substance Use Disorders
- +2 more
- Cognitive Behavioral Therapy
- (no location specified)
Jul 5, 2023
ADHD Trial in Hershey (CNS Stimulant)
Recruiting
- ADHD
- CNS Stimulant
-
Hershey, PennsylvaniaPenn State Hershey
Jul 18, 2022
Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders, Stimulant Dependence
Recruiting
- Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)
- +4 more
- Aripiprazole
- +2 more
-
Hong Kong, Hong KongQueen Mary Hospital
Aug 17, 2021
Cocaine Dependence Trial in Charlottesville, Richmond (Ondansetron, Placebo)
Substance Use Disorders Trial in Seoul (CDP-choline, Placebo, Supportive psychotherapy)
Recruiting
- Substance Use Disorders
- CDP-choline
- +2 more
-
Seoul, Korea, Republic ofEwha Womans University Mokdong Hospital
Jul 28, 2022
Adherence, Medication, HIV-1-infection, Stimulant Use Trial in Miami (START mHealth Intervention)
Recruiting
- Adherence, Medication
- +2 more
- START mHealth Intervention
-
Miami, FloridaUniversity of MIami
Jul 25, 2022
Attention Deficit/Hyperactivity Disorder, Initial Insomnia Trial in Edmonton (Melatonin, Placebo)
Withdrawn
- Attention Deficit/Hyperactivity Disorder
- Initial Insomnia
- Melatonin
- Placebo
-
Edmonton, Alberta, CanadaUniversity of Alberta
Nov 5, 2021
Breath Test, Oesophageal Cancer, Gastric Cancer Trial in London (Oral Stimulant Drink)
Not yet recruiting
- Breath Test
- +4 more
- Oral Stimulant Drink
-
London, United KingdomVolatile Biomarker Group, Commonwealth Building, Hammersmith Hos
Oct 30, 2022
Methamphetamine Use Disorder, Substance-Related Disorders, Chemically-Induced Disorders Trial in Madison (Psilocybin)
Recruiting
- Methamphetamine Use Disorder
- +4 more
-
Madison, WisconsinUniversity of Wisconsin
Jan 9, 2023
Cocaine Dependence, Methamphetamine Dependence, Nicotine Dependence Trial in United States (Smoking-cessation treatment)
Completed
- Cocaine Dependence
- +2 more
- Smoking-cessation treatment
-
Tucson, Arizona
- +11 more
Sep 27, 2021
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Fetal Alcohol Spectrum Disorders Trial in Clayton (Methylphenidate Hydrochloride, Placebo, Methylphenidate HCl)
Recruiting
- Fetal Alcohol Spectrum Disorders
- Methylphenidate Hydrochloride
- +4 more
-
Clayton, Victoria, AustraliaMonash Health
Feb 22, 2022
Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,
Recruiting
- Sleep Disorder
- Healthy
- Sleep Fragmentation
- +3 more
-
Baltimore, MarylandJohns Hopkins School of Medicine
Nov 14, 2022